Analgesics in Russia
Adult combination products registered the best value performance at the end of the review period in analgesics. This is explained by the fact that adult combination products do not fall under the state regulation of unit prices, unlike other types of analgesics that are listed as vital and essential medicines. This means that manufacturers of adult combination products are not limited in unit price increases and can reflect the investment expense of branding, promotion and advertising in the pro...
Euromonitor International's Analgesics in Russia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
- ANALGESICS IN RUSSIA
- Euromonitor International
- February 2019
- LIST OF CONTENTS AND TABLES
- Adult Combination Products - Analgesics Performs Best
- the Naturalness Trend Is More Evident in Topical Analgesics/anaesthetic
- Development of OTC Adult Diclofenac Is Constrained by Poor Control Over Sales of Rx Drugs
- Competitive Landscape
- Otcpharm Oao Maintains Its Leading Position in Consolidated Analgesics in 2018
- Support for the New Launch of Voltaren Emulgel
- Category Data
- Table 1 Sales of Analgesics by Category: Value 2013-2018
- Table 2 Sales of Analgesics by Category: % Value Growth 2013-2018
- Table 3 Sales of Topical Analgesics/Anaesthetic by Format: % Value 2013-2018
- Table 4 NBO Company Shares of Analgesics: % Value 2014-2018
- Table 5 LBN Brand Shares of Analgesics: % Value 2015-2018
- Table 6 Forecast Sales of Analgesics by Category: Value 2018-2023
- Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2018-2023
- Executive Summary
- Consumer Health Delivers Modest Growth
- Consumers Become Practical and Rational Consumer Health Purchasers
- Intense Competition in A Fragmented Competitive Landscape
- Consolidation of Pharmacy Retail Chains
- Sluggish Performance Expected in Russian Consumer Health
- Market Indicators
- Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018
- Table 9 Life Expectancy at Birth 2013-2018
- Market Data
- Table 10 Sales of Consumer Health by Category: Value 2013-2018
- Table 11 Sales of Consumer Health by Category: % Value Growth 2013-2018
- Table 12 NBO Company Shares of Consumer Health: % Value 2014-2018
- Table 13 LBN Brand Shares of Consumer Health: % Value 2015-2018
- Table 14 Distribution of Consumer Health by Format: % Value 2013-2018
- Table 15 Distribution of Consumer Health by Format and Category: % Value 2018
- Table 16 Forecast Sales of Consumer Health by Category: Value 2018-2023
- Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023
- OTC Registration and Classification
- Vitamins and Dietary Supplements Registration and Classification
- Self-medication/self-care and Preventive Medicine
- Summary 1 Research Sources